Special license plates bring in $1.2 million for State Road Fund
Special license plates bring in $1.2 million for State Road Fund
CHARLESTON, W.Va. — The Friends of Coal Association became the first nonprofit group to be approved for its own special license plates through the West Virginia Division of Motor Vehicles. In 2010, the Legislature approved a program that allows charitabl…
Read more on The Charleston Gazette
Categories: Breast Cancer Information Tags: $1.2, bring, Fund, License, million, plates, road, Special, State
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal …
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal …
Amgen today announced that the U.S. Food and Drug Administration has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events in patients with cancer.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: application, Biologics, Denosumab, Designation, Grants, License, priority, reduction, Review, Skeletal
Does your state have a breast cancer car license plate as an option?
I have only seen one other person in here in Arizona that has a breast cancer license plate like me. I was wondering if the state you live in has that option when customizing?
Thank you in advance for your answers.
Special license plate would aid breast cancer awareness
Special license plate would aid breast cancer awareness
Efforts to raise awareness about breast cancer and to help combat the disease would get a financial boost under legislation introduced Tuesday, May 4 by state Sen. Michael Katz (D-Centerville).
Read more on Smyrna Clayton Sun Times
Shionogi, QuatRx Pharmaceuticals enter into worldwide license agreement to develop and market ospemifene
Shionogi, QuatRx Pharmaceuticals enter into worldwide license agreement to develop and market ospemifene
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator (“SERM”).
Read more on News-Medical-Net
Categories: Breast Cancer Symptoms Tags: Agreement, develop, enter, into, License, Market, Ospemifene, Pharmaceuticals, QuatRx, Shionogi, worldwide
Shionogi Enters into Exclusive License Agreement with QuatRx Pharmaceuticals to Market Ospemifene
Shionogi Enters into Exclusive License Agreement with QuatRx Pharmaceuticals to Market Ospemifene
OSAKA, Japan—-Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company , a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator .
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Symptoms Tags: Agreement, Enters, Exclusive, into, License, Market, Ospemifene, Pharmaceuticals, QuatRx, Shionogi